Diabetes Therapy《糖尿病治疗》(可官网投稿)

Diabetes Therapy《糖尿病治疗》(月刊). Diabetes Therapy is an international, open access, peer-reviewed (single-blind), and rapid publication journal. The scope of the journal is broad, dedicated to the publication of high-quality clinical, observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions, including devices, across all areas of diabetes.

杂志简称:diabetes ther
中文译名:《糖尿病治疗》
收录属性:scie(2024版), 目次收录(维普),英文期刊,
自引率:10.30%
投稿方向:医学、endocrinology & metabolism 内分泌学与代谢

Diabetes Therapy《糖尿病治疗》

SCI/E期刊基本信息

出版周期:月刊 地区:英国
中科院分区:3区
是否TOP:非TOP期刊
是否综述:非综述期刊
是否OA:OA期刊
国际标准刊号:ISSN1869-6953;EISSN1869-6961
杂志语言:英语
出版国家:英国

杂志官网 联系方式

出版地址:SPRINGER HEIDELBERG,TIERGARTENSTRASSE 17,HEIDELBERG,GERMANY,D-69121
杂志邮箱:
投稿网址:https://www.editorialmanager.com/diat
杂志官方网址:https://www.springer.com/journal/13300
出版商网址:http://www.springer.com

杂志投稿要求

期刊相关咨询邮箱【杂志社官方网站信息】

Contact the journal

Submission-related enquiries

Queries about submission issues, peer review process, or the status of your manuscript should be sent to Monicka Prathap (monicka.prathap@springernature.com).

Production-related enquiries

Queries about accepted manuscripts in production or post-publication corrections should be sent to Priya Verma (Priya.Verma@springernature.com).

Rights and Permissions enquiries

For permission requests to reuse or reprint content, please follow the link ‘Rights and permissions’ on the relevant article page. For other queries, contact journalpermissions@springernature.com.

Publication-related enquiries

Queries related to journal publishing should be sent to Victoria Glasson (Victoria.Glasson@springernature.com).

投稿须知【杂志社官方网站信息】

Instructions for Authors

Aims and Scope

Diabetes Therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions (including devices) across all areas of diabetes. Studies relating to diagnostics and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged.

The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Diabetes Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.

Rapid Publication

The journal’s rapid publication timelines aim for a peer review decision within 2 weeks of submission. If an article is accepted it will be published online 3-4 weeks from acceptance. These rapid timelines are achieved through the combination of a dedicated in-house editorial team, who closely manage article workflow, and an extensive Editorial and Advisory Board who assist with rapid peer review. This allows the journal to support the rapid dissemination of research, whilst still providing robust peer review. Combined with the journal’s open access model this allows for the rapid and efficient communication of the latest research and reviews, allowing the advancement of clinical therapies.

Personal Service

The journal’s dedicated in-house editorial team offer a personal “concierge service” meaning that authors will always have a personal point of contact able to update them on the status of their manuscript. The editorial team check all manuscripts to ensure that articles conform to the most recent COPE, GPP and ICMJE publishing guidelines. This supports the publication of ethically sound and transparent research. We also encourage pre-submission enquiries and are always happy to provide a confidential assessment of manuscripts.

Digital features and plain language summaries

Diabetes Therapy offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by key summary points, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. If you consider that your paper would benefit from the inclusion of a digital feature, please let us know. Our editorial team are able to create high-quality slide decks and infographics in-house, and video abstracts through our partner Research Square, and would be happy to assist in any way we can. For further information about digital features, please contact the journal editor (see ‘Contact the Journal’ for email address), and see the ‘Guidelines for digital features and plain language summaries’ document under ‘Submission guidelines’.

Peer Review Process

Upon submission, manuscripts are assessed by the editorial team to ensure they fit within the aims and scope of the journal and are also checked for plagiarism. All suitable submissions are then subject to a comprehensive single-blind peer review. Reviewers are selected based on their relevant expertise and publication history in the subject area. The journal has an extensive pool of editorial and advisory board members who have been selected to assist with peer review based on the afore-mentioned criteria.

At least two extensive reviews are required to make the editorial decision, with the exception of some article types such as Commentaries, Editorials and Letters which are generally reviewed by one member of the Editorial Board. Where reviewer recommendations are conflicted, the editorial board will be contacted for further advice and a presiding decision.

Manuscripts are then either accepted, rejected or authors are required to make major or minor revisions (both reviewer comments and editorial comments may need to be addressed). Once a revised manuscript is re-submitted, it is assessed along with the responses to reviewer comments and if it has been adequately revised it will be accepted for publication. Accepted manuscripts are then copyedited and typeset by the production team before online publication. Appeals against decisions following peer review are considered on a case by case basis and should be sent to the journal editor.

Publication Fees

Upon acceptance of an article, authors will be required to pay the Rapid Service Fee of £4300/€5250/$6000. The journal will consider fee discounts for developing countries and this is decided on a case by case basis.

Open Access

All articles published by Diabetes Therapy are published open access

Preprints

We encourage posting of preprints of primary research manuscripts on preprint servers, authors’ or institutional websites, and open communications between researchers whether on community preprint servers or preprint commenting platforms. Posting of preprints is not considered prior publication and will not jeopardize consideration in our journals. Please follow the link for further information on preprint sharing:

https://www.springer.com/gp/authors-editors/journal-author/journal-author-helpdesk/submission/1302#c16721550

Copyright

Diabetes Therapy's content is published open access under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0

Contact

For more information about the journal, including pre-submission enquiries, please contact victoria.glasson@springer.com

PRESUBMISSION CHECKLIST

To submit a manuscript it is recommended that you use our Editorial Manager system. Please ensure that your submission meets our editorial polices as outlined in the instructions for authors provided below. Prior to submission, please use the following checklist to make sure you have the necessary information and files that are required to submit your manuscript.

Further information on how to submit your article can be found here.

Please note that there is a Rapid Service Fee that is mandatory for publications across our entire Rapid Plus journals portfolio. For more information on those compulsory fees, please see each journal website, under the heading – Aims and Scopes.

Information

 Article type (see here);

 Article title;

 Author information, including affiliations and e-mail addresses;

 Abstract (including the trial registration number, if applicable);

 Three to ten keywords;

 Additional information:

o The name, email, postal address, telephone number, and VAT number (where applicable; for registered EU companies) for financial correspondence;

o Copyright permissions for previously published figures and tables;

o Details of and reasons for any specific publication deadline;

o Information on where you heard about the journal;

o The email address of anyone, other than the corresponding author, who should receive manuscript correspondence throughout the publication process;

o Details of any enhanced features;

o Details of the ethics statements applicable to the study;

o Details of the trial Registration for the study;

o Advances in Therapy ONLY: Whether you require the article to be published open access; all other journals in the portfolio are fully open access.

 Details (name, affiliation, and email address) of three potential reviewers for your submission.

Recommended reviewers should not be from any of the authors' affiliations or institutions.

Please note that, although your help is appreciated and may speed up the selection of appropriate reviewers, the Editorial Team reserves the right to select reviewers.

Files

The following files are needed during the submission process. Each item in the checklist should be saved as a separate file.

 Manuscript including title page, abstract, keywords, 4-5 key summary points, main text, acknowledgments, references, tables, figure legends and line numbers;

 Figures (each figure should be saved as a separate file either as a JPG or tiff);

 Any supplementary material (optional);

 Any enhanced features (optional).

刊知网 精心整理,转载请注明出处:https://www.kanzhiwang.com/archives/43725

我要点评 请您把投稿经验分享出来 让大家少走弯路少踩坑,我为人人、人人为我。

内容纠错 您如果发现杂志信息有错漏 可以在下方留言。

上一篇 2024年11月9日 下午12:02
下一篇 2024年11月9日 下午12:02

相关推荐

发表回复

登录后才能评论

联系我们

191 1833 1195

在线咨询: QQ交谈

邮件:321628655@qq.com

工作时间:周一至周五,9:30-18:30,节假日休息